HK1057751A1 - A thiazolidinedione derivative and its use as antidiabetic - Google Patents

A thiazolidinedione derivative and its use as antidiabetic

Info

Publication number
HK1057751A1
HK1057751A1 HK03108591A HK03108591A HK1057751A1 HK 1057751 A1 HK1057751 A1 HK 1057751A1 HK 03108591 A HK03108591 A HK 03108591A HK 03108591 A HK03108591 A HK 03108591A HK 1057751 A1 HK1057751 A1 HK 1057751A1
Authority
HK
Hong Kong
Prior art keywords
compound
antidiabetic
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
HK03108591A
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1057751A1 publication Critical patent/HK1057751A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03108591A 2000-09-05 2003-11-25 A thiazolidinedione derivative and its use as antidiabetic HK1057751A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021784.4A GB0021784D0 (en) 2000-09-05 2000-09-05 Novel pharmaceutical
PCT/GB2001/003996 WO2002020520A1 (en) 2000-09-05 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
HK1057751A1 true HK1057751A1 (en) 2004-04-16

Family

ID=9898884

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108591A HK1057751A1 (en) 2000-09-05 2003-11-25 A thiazolidinedione derivative and its use as antidiabetic

Country Status (14)

Country Link
US (1) US20040044043A1 (ko)
EP (1) EP1315724B1 (ko)
JP (1) JP2004508370A (ko)
KR (1) KR100769008B1 (ko)
CN (1) CN1239501C (ko)
AT (1) ATE310000T1 (ko)
AU (1) AU2001284285A1 (ko)
CY (1) CY1105354T1 (ko)
DE (1) DE60115062T2 (ko)
DK (1) DK1315724T3 (ko)
ES (1) ES2248385T3 (ko)
GB (1) GB0021784D0 (ko)
HK (1) HK1057751A1 (ko)
WO (1) WO2002020520A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
ATE349444T1 (de) * 2001-11-21 2007-01-15 Smithkline Beecham Plc 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2008008895A1 (en) * 2006-07-13 2008-01-17 Smithkline Beecham Corporation Gpr119 agonists for the treatment of diabetes and related disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP1315724B1 (en) 2005-11-16
CN1239501C (zh) 2006-02-01
DE60115062T2 (de) 2006-06-29
CY1105354T1 (el) 2010-03-03
WO2002020520A1 (en) 2002-03-14
GB0021784D0 (en) 2000-10-18
CN1471529A (zh) 2004-01-28
KR100769008B1 (ko) 2007-10-22
KR20030027112A (ko) 2003-04-03
US20040044043A1 (en) 2004-03-04
EP1315724A1 (en) 2003-06-04
DK1315724T3 (da) 2006-02-20
DE60115062D1 (de) 2005-12-22
ATE310000T1 (de) 2005-12-15
AU2001284285A1 (en) 2002-03-22
ES2248385T3 (es) 2006-03-16
JP2004508370A (ja) 2004-03-18

Similar Documents

Publication Publication Date Title
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
NZ515166A (en) Thiazolidinedione derivative and its use as antidiabetic
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
PT1349855E (pt) Sal misilato de 5-{4-[2-(n-metil-n-(2-piridil)amino)etoxi]benzil}tiazolidino-2, 4-diona
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AU2002343052A1 (en) Rosiglitazone edisylates and their use as antidiabetics
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
AP2003002737A0 (en) Tartrate salts of thiazolidinedione derivatives
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
AP1813A (en) Tartrate salts of thiazolidinedione derivative.
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
ECSP003434A (es) Nuevos compuestos

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100905